✦ LIBER ✦

Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia

✍ Scribed by R. Williams; L. Kopala; A. Malla; G. Smith; L. Love; R. Balshaw

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Canadian National Outcomes Measureme

✍ G. Smith; A. Malla; R. Williams; L Kopala; L. Love; R. Balshaw 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

PMH12: THE COST OF TREATING SCHIZOPHRENI

✍ K Trakas; D Lin; R Balshaw; K Robinson; E Andrew 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Risk of adverse events associated with a

✍ R. McIntyre; K. Trakas; P. Hwang; D. Lin; R. Balshaw; K. Robinson; A. Eggleston 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 152 KB

PMH14: COST OF CARE IN SCHIZOPHRENIA PAT

✍ MA Atkinson; LC Kopala; AK Malla; G Smith; R Williams 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PMH4 2-YEAR OUTCOMES OF RISPERDAL® CONST

✍ K Trakas; D Talling; R Balshaw; L Love; K Robinson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

RELATIONSHIPS AMONG MULTIPLE OUTCOME MEA

✍ Lei Chen; Glenn A. Phillips; Joseph Johnston; Virginia Stauffer; Bruce J. Kinon; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 67 KB